David Vitter actually said...

"I think a European registration, evaluation and authorization of chemical substances, a REACH-style program, would threaten to kill innovation in the United States."

"I think the peer review process needs to ensure that the peers are absolutely independent."

"The main priority I want to stress is the importance of basing everything on sound and rigorous science."

"I think these numbers, which are strong in dollar figures, in claimants paid, in many ways, do represent the easiest cases."